QuadMedicine, Inc. (KOSDAQ:464490)
South Korea · Delayed Price · Currency is KRW 5,620.00
-320.00 (-5.39%)
At close: Jul 21, 2026
QuadMedicine Market Cap
QuadMedicine has a market cap or net worth of 64.53 billion as of July 21, 2026.
Market Cap
64.53B
Enterprise Value
47.62B
Revenue
9.78B
Ranking
n/a
PE Ratio
n/a
Stock Price
5,620.00
ChartMarket Cap Chart
Since December 12, 2025, QuadMedicine's market cap has decreased from 199.95B to 64.53B, a decrease of -67.73%. That is a compound annual growth rate of -84.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 64.53B | -63.50% |
| Dec 30, 2025 | 176.81B | -11.57% |
| Dec 12, 2025 | 199.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CORESTEMCHEMON | 83.18B |
| SunBio,Inc. | 75.11B |
| BIO-FD&C | 72.78B |
| CTCBIO | 70.05B |
| AriBioLab | 67.82B |
| EyeGene | 64.46B |
| KoBioLabs | 63.40B |
| PanGen Biotech | 61.69B |